November 2025, From the Field
Practical guidance to support your journey—from saving to investing to retirement.
1 See Tim Murray’s T. Rowe Price white paper, “Have U.S. Stocks Become Too Expensive?”
2 Dividends are not guaranteed and are subject to change.
3 See John Hall’s T. Rowe Price white paper, “Drugging the Undruggable: How Biotech Innovation is Creating Opportunity for Investors.”
Risks:
Growth stocks are subject to the volatility inherent in common stock investing, and their share price may fluctuate more than that of a income‑oriented stocks. Diversification cannot assure a profit or protect against loss in a declining market. Investing in technology stocks entails specific risks, including the potential for wide variations in performance and usually wide price swings, up and down. Technology companies can be affected by, among other things, intense competition, government regulation, earnings disappointments, dependency on patent protection and rapid obsolescence of products and services due to technological innovations or changing consumer preferences. Health sciences firms are often dependent on government funding and regulation and are vulnerable to product liability lawsuits and competition from low‑cost generic product. Active investing may have higher costs than passive investing and may underperform the broad market or passive peers with similar objectives. All charts and tables are shown for illustrative purposes only.
Additional Disclosure
For U.S. investors, visit troweprice.com/glossary for definitions of financial terms.
Please see vendor indices disclaimers for more information about the sourcing information: www.troweprice.com/marketdata
Important Information
Outside of the United States, this is intended for investment professional use only. Not for further distribution.
This material is being furnished for informational and/or marketing purposes only and does not constitute an offer, recommendation, advice, or solicitation to sell or buy any security.
Prospective investors should seek independent legal, financial and tax advice before making any investment decision. T. Rowe Price group of companies including T. Rowe Price Associates, Inc. and/or its affiliates receive revenue from T. Rowe Price investment products and services.
Past performance is not a guarantee or a reliable indicator of future results. All investments involve risk, including possible loss of principal.
Information presented has been obtained from sources believed to be reliable, however, we cannot guarantee the accuracy or completeness. The views contained herein are those of the author(s), are as of November 2025, are subject to change, and may differ from the views of other T. Rowe Price Group companies and/or associates. Under no circumstances should the material, in whole or in part, be copied or redistributed without consent from T. Rowe Price.
All charts and tables are shown for illustrative purposes only. Actual future outcomes may differ materially from any estimates or forward‑looking statements provided.
The material is not intended for use by persons in jurisdictions which prohibit or restrict the distribution of the material and in certain countries the material is provided upon specific request.
USA—Issued in the USA by T. Rowe Price Investment Services, Inc., distributor and T. Rowe Price Associates, Inc., investment adviser, 1307 Point Street, Baltimore, MD 21231, which are regulated by the Financial Industry Regulatory Authority and the U.S. Securities and Exchange Commission, respectively.
© 2025 T. Rowe Price. All Rights Reserved. T. Rowe Price, INVEST WITH CONFIDENCE, the Bighorn Sheep design, and related indicators (see troweprice.com/ip) are trademarks of T. Rowe Price Group, Inc. All other trademarks are the property of their respective owners.
202511-4979307